InvestorsHub Logo

justdafactss

02/12/20 6:29 PM

#98338 RE: gint1 #98333

And where is Ichim's name listed as a author of the peer reviewed article entitled Phase I and registry study of autologous bone marrow concentrate evaluated in PDE5 inhibitor refractory erectile dysfunction?

https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-019-02195-w

Cant blame him for taking a pass on it.

Just look at the share price and total lack of interest from the medical community.

BigB111

02/13/20 8:37 AM

#98370 RE: gint1 #98333

Mr. Incompetent CEO Tim Warbington
?
"I am thrilled with the effort of our team and am confident the fruit of their labor will come to the
forefront as we close out the year," commented Timothy Warbington, President and CEO of Creative Medical Technology Holdings, Inc. "I would also like to take a moment to thank our committed shareholders, as we recognize the stock price has not been reflective of the intrinsic value we have built in the company. Please rest assured we remain committed to increasing shareholder value, and believe your patience will be greatly rewarded in the near future."

1 DAY LATER

ANNOUNCE REVERSE SPLIT which occurred on 2/3

We still have heard anything since this famous "We promised, We Delivered" PR back in OCTOBER 2019 and that didn't tell us anything!

So where oh where is Mr. Incompetent???